You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sars-Cov-2 immunization

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Against Sars-Cov2 Virus in Received EU-approved COVID-19

Completed
  • SARS-CoV2 Infection
  • Vaccine Reaction
  • Approved vaccines against Sars-Cov2
  • Patras, Greece
    University Hospital of Patras
Jun 2, 2022

COVID-19 Trial in Nanjing (Recombinant SARS-CoV-2 Ad5 vectored vaccine, Inactive SARS-CoV-2 vaccine (Vero cell))

Completed
  • COVID-19
  • Recombinant SARS-CoV-2 Ad5 vectored vaccine
  • Inactive SARS-CoV-2 vaccine (Vero cell)
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Mar 28, 2022

COVID-19 Pandemic Trial in Zhuhai (Recombinant SARS-CoV-2 Fusion Protein Vaccine 10µg, Recombinant SARS-CoV-2 Fusion Protein

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine 10μg
  • +2 more
  • Zhuhai, Guangdong, China
    Zhuhai Peoples' Hospital Medical Group
Mar 12, 2022

COVID-19 Pandemic Trial in Zhuhai (Recombinant SARS-CoV-2 Fusion Protein Vaccine)

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine
  • Zhuhai, Guangdong, China
    The Fifth Peoples' Hospital of Zhuhai
Feb 15, 2022

Follicular Lymphoma, Mantle Cell Lymphoma Trial in Rouen (Determination of COVID-19 vacciantion efficacy)

Completed
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • Determination of COVID-19 vacciantion efficacy
  • Rouen, France
    Centre Henri Becquerel
Dec 22, 2022

COVID19 Trial in Guangzhou (Recombinant SARS-CoV-2 Fusion Protein Vaccine)

Completed
  • COVID19
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine
  • Guangzhou, Guangdong, China
    Guangdong Provincial Center for Disease Control and Prevention
Feb 10, 2022

COVID-19 Trial (ABO1009-DP)

Not yet recruiting
  • COVID-19
  • ABO1009-DP
  • (no location specified)
Jul 11, 2022

Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis

Recruiting
  • SARS-CoV-2 Infection
  • +3 more
    • Dresden, Saxony, Germany
      Univercity Hospital Carl Gustav Carus
    Aug 2, 2022

    Vaccine Adverse Reaction, COVID-19, Vaccine Reaction Trial in San Nicolás De Los Garza (COVID-19 Vaccines)

    Recruiting
    • Vaccine Adverse Reaction
    • +2 more
    • COVID-19 Vaccines
    • San Nicolás De Los Garza, Mexico
      Hospital Clinica Nova de Monterrey
    Mar 25, 2022

    COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))

    Completed
    • COVID-19
    • Recombinant Novel Coronavirus vaccine (CHO Cells)
    • Changsha, Hunan, China
      Hunan Provincial Center for Disease Control and Prevention
    Jun 6, 2023

    SARS-CoV2 Infection Trial in Mile (SARS-CoV-2 Vaccine, Inactivated (Vero Cell))

    Recruiting
    • SARS-CoV2 Infection
    • SARS-CoV-2 Vaccine, Inactivated (Vero Cell)
    • Mile, Yunnan, China
      Mile City Centers for Disease Control and Prevention
    Feb 14, 2022

    COVID-19 Pandemic Trial in Malaysia, Pakistan (Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01), Blank Preparation of

    Active, not recruiting
    • COVID-19 Pandemic
    • Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
    • Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
    • Kuching, Sarawak, Malaysia
    • +17 more
    Aug 31, 2022

    COVID-19 Pandemic Trial in Zhuhai (Recombinant SARS-CoV-2 Fusion Protein Vaccine)

    Active, not recruiting
    • COVID-19 Pandemic
    • Recombinant SARS-CoV-2 Fusion Protein Vaccine
    • Zhuhai, Guangdong, China
      Zhuhai Peoples' Hospital Medical Group
    Nov 14, 2021

    SARS-CoV-2 Infection Trial in Anning (SARS-CoV-2 Vaccine, Inactivated (Vero Cell))

    Recruiting
    • SARS-CoV-2 Infection
    • SARS-CoV-2 Vaccine, Inactivated (Vero Cell)
    • Anning, Yunnan, China
      Anning First People's Hospital
    Feb 14, 2022

    Determine Antibody Levels After Receiving COVID-19 Boosters of

    Completed
    • SARS-CoV-2
      • San Mateo, California
        Evidation Health
      Oct 12, 2022

      COVID-19 Trial in Nanjing (Ad5-nCoV-IH, Ad5-nCoV-IM, CoronaVac)

      Active, not recruiting
      • COVID-19
      • Ad5-nCoV-IH
      • +2 more
      • Nanjing, Jiangsu, China
        Jiangsu Provincial Center for Diseases Control and Prevention
      Aug 12, 2022

      COVID-19, SARS-CoV-2 Trial in Moscow, St Petersburg (Biological: AZD3152, Biological: Placebo)

      Not yet recruiting
      • COVID-19, SARS-CoV-2
      • Biological: AZD3152
      • Biological: Placebo
      • Moscow, Russian Federation
      • +5 more
      Sep 26, 2023

      Severe Acute Respiratory Syndrome Coronavirus Type 2-Related

      Recruiting
      • Multiple Sclerosis (MS)
        • Bamberg, Germany
        • +11 more
        Jan 17, 2022

        Coronavirus Infection Trial (INO-4800, INO-9112, CELLECTRA® 2000)

        Not yet recruiting
        • Coronavirus Infection
        • (no location specified)
        Jun 21, 2022

        SARS-CoV-2 Infection Trial in Mexico (AVX-COVID/12, ChAdOx-1-S[recombinant])

        Recruiting
        • SARS-CoV-2 Infection
        • AVX-COVID/12
        • ChAdOx-1-S[recombinant]
        • Mexico City, Cdmx, Mexico
        • +13 more
        Feb 3, 2023

        COVID-19 Pandemic Trial in Shaoguan (Recombinant SARS-CoV-2 Beta Variant Fusion Protein Vaccine/Recombinant SARS-CoV-2 Delta

        Active, not recruiting
        • COVID-19 Pandemic
        • Recombinant SARS-CoV-2 Beta Variant Fusion Protein Vaccine/Recombinant SARS-CoV-2 Delta Variant Fusion Protein Vaccine
        • Shaoguan, Guangdong, China
          Shaoguan Hospital of Chinese Medicine
        Mar 1, 2022

        Healthy, Immunization; Infection Trial in France (3 doses of BNT162b2 vaccine, 2 dose of BNT162b2 vaccine)

        Active, not recruiting
        • Healthy
        • Immunization; Infection
        • 3 doses of BNT162b2 vaccine
        • 2 dose of BNT162b2 vaccine
        • Brest, France
        • +10 more
        Sep 2, 2022

        SARS-CoV-2 Acute Respiratory Disease Trial (SARS-Cov-2 mRNA vaccine immunization, Inactivated SARS-Cov-2 vaccine immunization)

        Not yet recruiting
        • SARS-CoV-2 Acute Respiratory Disease
        • SARS-Cov-2 mRNA vaccine immunization
        • Inactivated SARS-Cov-2 vaccine immunization
        • (no location specified)
        Jun 28, 2021

        SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

        Not yet recruiting
        • SARS-CoV-2 Infection
        • +4 more
        • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
        • +2 more
        • Shanghai, Shanghai, China
          Shanghai Municipal Center for Disease Control and Prevention
        Jul 17, 2023

        Covid19 Trial in Marseille (Blood sample)

        Recruiting
        • Covid19
        • Blood sample
        • Marseille, France
          Assistance Publique Des Hopitaux de Marseille
        Aug 18, 2021